oral glp 1 lilly Eli Lilly's GLP-1 for type 2 diabetes submission in the U.S Eli Lilly's oral GLP-1 for

Innovative pharmacological options are required to cope with the global diabesity pandemic

The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo Nordisk and Eli Lilly, who want to protect their right to sell their patent | Novo Nordisk has asked the FDA to prevent compounders from manufacturing copycat versions of its juggernaut diabetes and obesity treatments Ozempic and Wegovy, claiming the drugs are too complex to safely replicate.

Body aches experienced with GLP-1 medications typically do subside over time as the body adjusts to the medication

Used consistently, it helps reduce food noise, supports portion awareness, and promotes a calm, more intuitive relationship with food